Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Current Assets:
Cash and cash equivalents	$ 23,355	$ 41,419
Available-for-sale securities	11,819	3,933
Accounts receivable, net of allowances of $86 and $80 as of December 31, 2023 and September 30, 2023, respectively	12,919	10,850
Contract assets	9,178	7,796
Inventories, net	14,438	14,839
Income tax receivable	361	491
Prepaids and other	7,738	7,363
Total Current Assets	79,808	86,691
Property and equipment, net	25,563	26,026
Intangible assets, net	26,213	26,206
Goodwill	44,283	42,946
Other assets	4,373	3,864
Total Assets	180,240	185,733
Current Liabilities:
Accounts payable	2,581	2,993
Accrued liabilities:
Compensation	4,079	10,139
Accrued other	5,809	6,444
Deferred revenue	4,008	4,378
Total Current Liabilities	16,477	23,954
Long-term debt, net	29,443	29,405
Deferred revenue, less current portion	1,648	2,400
Deferred income taxes	1,992	2,004
Other long-term liabilities	8,530	8,060
Total Liabilities	58,090	65,823
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Series A Preferred stock - $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock - $.05 par value, 45,000 shares authorized; 14,235 and 14,155 shares issued and outstanding as of December 31, 2023 and September 30, 2023, respectively	712	708
Additional paid-in capital	37,621	36,706
Accumulated other comprehensive loss	(2,652)	(4,759)
Retained earnings	86,469	87,255
Total Stockholders’ Equity	122,150	119,910
Total Liabilities and Stockholders’ Equity	$ 180,240	$ 185,733